Edaravone Injection 30 mg/10 ml Suppliers & Bulk Manufacturers
Available Forms: Injectable Solution
Available Strengths: 30 mg/10 ml
Reference Brands: Radicava(US)
Category: Orphan Drugs
Edaravone is a free radical scavenger that reduces oxidative stress in neurons, protecting against nerve cell damage. It slows ALS progression, improves muscle strength, and prolongs survival. Benefits include neuroprotection, symptom stabilization, and improved quality of life for ALS patients by supporting neuronal health.
Product Description:
Edaravone injection, marketed as Radicava, is approved in the US by the FDA and in the EU via EMA for amyotrophic lateral sclerosis (ALS). Regulatory approval requires comprehensive dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety and manufacturing compliance. For guidance on dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Supporting regional adherence supports quick approval, safe administration, and global availability, helping ALS patients worldwide by slowing disease progression and improving quality of life through neuroprotective mechanisms.
Edaravone Injection — third party manufacturing & bulk supply
Edaravone Injection 30 mg/10 ml is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Edaravone Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Edaravone Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Edaravone is used to slow the progression of amyotrophic lateral sclerosis (ALS), a neurodegenerative disease affecting motor neurons.
Edaravone is a free radical scavenger that reduces oxidative stress. Its chemical name is 3-methyl-1-phenyl-2-pyrazolin-5-one.
Edaravone is marketed under the brand names Radicava and Radicava ORS in the USA. No authorized brands are currently marketed in the EU or UK.
Edaravone is manufactured by Mitsubishi Tanabe Pharma Corporation in the USA under the brand name Radicava.
The generic name is Edaravone.
Brand names include Radicava and Radicava ORS (USA).
Edaravone is manufactured in the USA by Mitsubishi Tanabe Pharma Corporation.
Related Products
Pasireotide Diaspartate
Strength:
0.3 mg/mL, 0.6 mg/mL, 1.2 mg/mL, 10 mg, 20 mg, 30 mg
Form: Injection
Reference Brands: Signifor (USA/EU)
View Details
Sepiapterin
Strength:
1000 mg, 250 mg
Form: Tablets / oral powder
Reference Brands: Sephience (USA/EU)
View Details
Glycerol Phenylbutyrate
Strength:
1.1 g/mL
Form: Oral Solution
Reference Brands: Ravicti (USA)
View DetailsQuick Response Guaranteed | Verified Suppliers
